Mohammed Dar Selected Research

Tovetumab

1/2019

Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammed Dar Research Topics

Disease

1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Edema (Dropsy) 01/2018
1	Glioma (Gliomas) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Merkel Cell Carcinoma 09/2009

Drug/Important Bio-Agent (IBA)

2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018
2	PlatinumIBA 01/2019 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 01/2018
1	TovetumabIBA 01/2019
1	Angiopoietin-2IBA 01/2018
1	MEDI3617IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 09/2009
1	pazopanib FDA Link 09/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2019